Form 8-K - Current report:
SEC Accession No. 0001640334-25-000025
Filing Date
2025-01-06
Accepted
2025-01-06 16:15:26
Documents
16
Period of Report
2024-12-26
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K yubo_8k.htm   iXBRL 8-K 26650
2 LETTER FROM MICHAEL yubo_ex161.htm EX-16.1 2079
  Complete submission text file 0001640334-25-000025.txt   150380

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA yubo-20241226.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE yubo-20241226_lab.xml EX-101.LAB 14189
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE yubo-20241226_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE yubo-20241226_pre.xml EX-101.PRE 8943
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE yubo-20241226_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT yubo_8k_htm.xml XML 3791
Mailing Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000
Business Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000 86 (010) 6615-5141
Yubo International Biotech Ltd (Filer) CIK: 0000895464 (see all company filings)

EIN.: 113074326 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21320 | Film No.: 25511291
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)